6030-2123 Screening compound: N-[2-(3,4-dimethoxyphenyl)ethyl]-3-(2-hydroxy-3-methylphenyl)-3-phenylpropanamide

6030-2123 Screening compound: N-[2-(3,4-dimethoxyphenyl)ethyl]-3-(2-hydroxy-3-methylphenyl)-3-phenylpropanamide
6030-2123 Screening compound: N-[2-(3,4-dimethoxyphenyl)ethyl]-3-(2-hydroxy-3-methylphenyl)-3-phenylpropanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 6030-2123
N-[2-(3,4-dimethoxyphenyl)ethyl]-3-(2-hydroxy-3-methylphenyl)-3-phenylpropanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

6030-2123

Molecular Formula

C26H29NO4 (C26 H29 NO4)

Compound Name

N-[2-(3,4-dimethoxyphenyl)ethyl]-3-(2-hydroxy-3-methylphenyl)-3-phenylpropanamide

IUPAC name

N-[2-(34-dimethoxyphenyl)ethyl]-3-(2-hydroxy-3-methylphenyl)-3-phenylpropanamide

SMILES

Cc1cccc(C(CC(NCCc(cc2)cc(OC)c2OC)=O)c2ccccc2)c1O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

419.52

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.102

Distribution Coefficient, logD

4.102

Water Solubility, LogSw

-4.21

Polar Surface Area

54.748

Acid Dissociation Constant (pKa)

11.67

Base Dissociation Constant (pKb)

-0.98

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

26.90

6030-2123 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

DGK Inhibitors Library (10558 compounds)

Human GPCR Annotated Library (5539 compounds)

Selective Target Activity Profiling Library (14702 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Kinases
  • Phosphatases

References: we are preparing a list of scientific research reports with 6030-2123 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 6030-2123?
Check Price and Availability of 6030-2123, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 6030-2123 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 6030-2123
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 6030-2123
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 6030-2123 available by request